home / stock / ntox / ntox short
Short Information | Notox Technologies Corp (OTCMKTS:NTOX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,800 |
Total Actual Volume | 2,500 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 6 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 90 |
Average Short Percentage | 30.33% |
Is there a NTOX Short Squeeze or Breakout about to happen?
See the NTOX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-20-2021 | $1.01 | $1.01 | $1.01 | $1.01 | 700 | 700 | 100% |
01-15-2021 | $1.5 | $1.5 | $1.5 | $1.5 | 100 | 100 | 100% |
01-06-2021 | $2.5 | $2.5 | $2.5 | $2.5 | 300 | 200 | 66.67% |
12-29-2020 | $2.5 | $2.5 | $2.5 | $2.5 | 100 | 100 | 100% |
04-30-2020 | $1.1 | $1.01 | $1.1 | $1.01 | 1,000 | 400 | 40% |
12-23-2019 | $3.61 | $3.61 | $3.61 | $3.61 | 200 | 200 | 100% |
12-16-2019 | $3.61 | $3.61 | $3.61 | $3.61 | 100 | 100 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Notox Technologies Corp Company Name:
NTOX Stock Symbol:
OTCMKTS Market:
Richmond Hill, Ontario--(Newsfile Corp. - June 15, 2022) - Notox Technologies Corp. (OTC: NTOX) ("Notox" or the "Company") is pleased to announce the appointment of Mary Kander to the Company's Medical Advisory Board. Ms. Kander is a Senior Consultant with Wave Strategy LLC, a consulting firm...
Richmond Hill, Ontario--(Newsfile Corp. - March 15, 2022) - Notox Technologies Corp. (OTC: NTOX) ("Notox" or the "Company") is pleased to announce that the Company has entered into an amendment with the Cleveland Clinic Foundation (the "Clinic") and Notox Bioscience Inc., the Company's wholly ...
Richmond Hill, Ontario--(Newsfile Corp. - December 15, 2021) - Notox Technologies Corp. (OTC: NTOX) ("Notox" or the "Company") is pleased to announce that the Company has engaged Ximedica, a Veranex company, to complete the design of the Notox apparatus in anticipation of seeking USFDA approva...